The Joint Corp. (JYNT)
NASDAQ: JYNT · Real-Time Price · USD
8.94
+0.09 (1.02%)
At close: Dec 24, 2025, 1:00 PM EST
8.80
-0.14 (-1.57%)
After-hours: Dec 24, 2025, 4:08 PM EST
The Joint Revenue
The Joint had revenue of $13.38M in the quarter ending September 30, 2025, with 5.74% growth. This brings the company's revenue in the last twelve months to $54.44M, up 8.54% year-over-year. In the year 2024, The Joint had annual revenue of $52.16M with 11.04% growth.
Revenue (ttm)
$54.44M
Revenue Growth
+8.54%
P/S Ratio
2.51
Revenue / Employee
$73,609
Employees
736
Market Cap
132.90M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 52.16M | 5.19M | 11.04% |
| Dec 31, 2023 | 46.98M | -54.27M | -53.60% |
| Dec 31, 2022 | 101.25M | 21.24M | 26.55% |
| Dec 31, 2021 | 80.01M | 21.33M | 36.34% |
| Dec 31, 2020 | 58.68M | 10.23M | 21.12% |
| Dec 31, 2019 | 48.45M | 11.79M | 32.16% |
| Dec 31, 2018 | 36.66M | 11.74M | 47.12% |
| Dec 31, 2017 | 24.92M | 4.40M | 21.42% |
| Dec 31, 2016 | 20.52M | 6.69M | 48.34% |
| Dec 31, 2015 | 13.84M | 6.72M | 94.41% |
| Dec 31, 2014 | 7.12M | 1.33M | 22.91% |
| Dec 31, 2013 | 5.79M | 3.11M | 116.09% |
| Dec 31, 2012 | 2.68M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
JYNT News
- 14 days ago - The Joint Corp. Signs Asset Purchase Agreement to Sell 22 Corporate Clinics in the Southeast and Delivers Notice to Terminate APA for 45 Clinics in California - GlobeNewsWire
- 5 weeks ago - Give Your Back a Break this Holiday with The Joint Chiropractic's "Back Friday Deals" - PRNewsWire
- 6 weeks ago - The Joint Corp. (JYNT) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - The Joint Chiropractic Continues Climb on the Franchise Times Top 400 List - PRNewsWire
- 2 months ago - The Joint Chiropractic Debuts in Delaware - PRNewsWire
- 3 months ago - The Joint Corp. Names Debbie L. Gonzalez Chief Marketing Officer - GlobeNewsWire
- 4 months ago - The Joint Corp. (JYNT) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 5 months ago - The Joint Corp. Expects to Restate Full Year 2024 and First Quarter 2025 Financial Statements due to Overestimated Noncash Impairment Charges - GlobeNewsWire